Poxel SA
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases. It also develops treatments for rare metabolic diseases and associated steatohepatitis to metabolic dysfunction. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the tr… Read more
Poxel SA (POXEL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.124x
Based on the latest financial reports, Poxel SA (POXEL) has a cash flow conversion efficiency ratio of -0.124x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.59 Million) by net assets (€-61.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Poxel SA - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Poxel SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Poxel SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Poxel SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Motorsport Gaming Us LLC
NASDAQ:MSGM
|
0.303x |
|
Eternal Energy Public Company Limited
BK:EE
|
-0.078x |
|
Sleep Cycle AB
ST:SLEEP
|
0.150x |
|
LLORENTE + CUENCA EO -01
F:91P
|
N/A |
|
Metallis Resources Inc
OTCQB:MTLFF
|
-1.850x |
|
URBAS GRP.FINANC. EO 001
F:UZY
|
N/A |
|
Pharmigene, Inc.
TWO:7595
|
-0.124x |
|
Kintech Electronics Co Ltd
TWO:6210
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Poxel SA (2011–2024)
The table below shows the annual cash flow conversion efficiency of Poxel SA from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-58.94 Million | €-17.61 Million | 0.299x | +4.88% |
| 2023-12-31 | €-49.08 Million | €-13.98 Million | 0.285x | -76.18% |
| 2022-12-31 | €-18.24 Million | €-21.81 Million | 1.196x | +158.09% |
| 2021-12-31 | €8.21 Million | €-16.89 Million | -2.059x | -114.90% |
| 2020-12-31 | €26.88 Million | €-25.75 Million | -0.958x | -45.94% |
| 2019-12-31 | €39.14 Million | €-25.69 Million | -0.656x | -671.83% |
| 2018-12-31 | €55.78 Million | €-4.74 Million | -0.085x | -120.23% |
| 2017-12-31 | €19.33 Million | €8.13 Million | 0.420x | +187.86% |
| 2016-12-31 | €39.39 Million | €-18.85 Million | -0.479x | -80.88% |
| 2015-12-31 | €38.03 Million | €-10.06 Million | -0.265x | -111.07% |
| 2014-12-31 | €-2.55 Million | €-6.09 Million | 2.390x | +614.70% |
| 2013-12-31 | €-20.01 Million | €-6.69 Million | 0.334x | +101.87% |
| 2012-12-31 | €315.03K | €-5.64 Million | -17.912x | -1489.45% |
| 2011-12-31 | €7.35 Million | €-8.28 Million | -1.127x | -- |